Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
Main Authors: | Henrik H Hansen, Urmas Roostalu, Jacob Hecksher-Sørensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=12;spage=2255;epage=2257;aulast=Hansen |
Similar Items
-
Whole-brain activation signatures of weight-lowering drugs
by: Henrik H. Hansen, et al.
Published: (2021-05-01) -
3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
by: Urmas Roostalu, et al.
Published: (2020-12-01) -
Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease
by: Urmas Roostalu, et al.
Published: (2019-11-01) -
A developmental analysis of the mouse mutant dominant hemimelia (Dh)
by: Hecksher-Sørensen, Jacob
Published: (2003) -
Whole-Brain Three-Dimensional Profiling Reveals Brain Region Specific Axon Vulnerability in 5xFAD Mouse Model
by: Jianping Zhang, et al.
Published: (2020-11-01)